DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
| MO-C930-GePD-F4-6 | Feasibility Study of Focal Salvage High Dose Rate (HDR) Brachytherapy After Neurovascular-Sparing Prostate Stereotactic Ablative Radiation Therapy (SAbR) N Hassan Rezaeian*, B Gannavarapu , R Hannan , M Folkert , A Garant , R Timmerman , B Hrycushko , N Desai , The University of Texas Southwestern Medical Ctr, Indianapolis, IN |
| PO-GePV-M-10 | Dosimetric Impact of Forced Densities Over the Course of RT D Schott1*, S Lim1 , R Thapa1 , D Prah1 , X Li1 , E Paulson1 , (1) Medical College of Wisconsin, Milwaukee, WI |
| PO-GePV-T-228 | The Influence of Large Training Sets Created with the Eclipse Scripting API in Custom RapidPlan Models J Rogers*, M DiMascio , Atrium Health, Rock Hill, SC |
| SU-F-302-8 | Variability of Gamma Knife Output Calibration Based On Chamber Type, Phantom Material, and Dosimetry Protocol A Boczkowski1*, S Graves2 , L Poplawski3 , D Hyer4 , (1) University of Iowa, Iowa City, Iowa, (2) University Of Iowa, Iowa City, IA, (3) West Virginia University, Morgantown, WV, (4) University of Iowa, Iowa City, IA |
| TH-BC-301-5 | Development and Implementation of a Small Field Calibration Procedure for a Novel Stereotactic Radiosurgery Device Utilizing TG-21 & IAEA TRS 483 S Becker*, E Nichols , B Yi , Univ. of Maryland School Of Medicine, Baltimore, MD |
| WE-I-SAN4-0 | Point/Counterpoint Live Debate: Modern Linacs Monitor Units Should Be Defined in Water at 10 Cm Depth Rather Than at DMAX F Van den Heuvel1*, Q Wu2*, K Kielar3*, C Sandin4*, F Van den Heuvel5*, (1) University of Oxford, Oxford, ,(2) Duke University Medical Center, Durham, NC, (3) Varian Medical Systems, Palo Alto, CA, (4) Elekta Ltd, Crawley, WSX, (5) University of Oxford, Oxford, United Kingdom |
| WE-I-SAN4-1 | I think that Linacs should be calibrated at d_max. No wait! I changed my mind! No it should! I am confused. F Van den Heuvel1*, Q Wu2*, K Kielar3*, C Sandin4*, F Van den Heuvel5*, (1) University of Oxford, Oxford, ,(2) Duke University Medical Center, Durham, NC, (3) Varian Medical Systems, Palo Alto, CA, (4) Elekta Ltd, Crawley, WSX, (5) University of Oxford, Oxford, United Kingdom |
| WE-I-SAN4-2 | Panel Member F Van den Heuvel1*, Q Wu2*, K Kielar3*, C Sandin4*, F Van den Heuvel5*, (1) University of Oxford, Oxford, ,(2) Duke University Medical Center, Durham, NC, (3) Varian Medical Systems, Palo Alto, CA, (4) Elekta Ltd, Crawley, WSX, (5) University of Oxford, Oxford, United Kingdom |
| WE-I-SAN4-3 | Panel Member C Wessels*, Varian Medical Systems, Ennetbaden, AG |
| WE-I-SAN4-4 | Panel Member F Van den Heuvel1*, Q Wu2*, K Kielar3*, C Sandin4*, F Van den Heuvel5*, (1) University of Oxford, Oxford, ,(2) Duke University Medical Center, Durham, NC, (3) Varian Medical Systems, Palo Alto, CA, (4) Elekta Ltd, Crawley, WSX, (5) University of Oxford, Oxford, United Kingdom |
| WE-I-SAN4-5 | Panel Member F Van den Heuvel1*, Q Wu2*, K Kielar3*, C Sandin4*, F Van den Heuvel5*, (1) University of Oxford, Oxford, ,(2) Duke University Medical Center, Durham, NC, (3) Varian Medical Systems, Palo Alto, CA, (4) Elekta Ltd, Crawley, WSX, (5) University of Oxford, Oxford, United Kingdom |
| WE-I-SAN4-6 | Panel Discussion F Van den Heuvel1*, Q Wu2*, K Kielar3*, C Sandin4*, F Van den Heuvel5*, (1) University of Oxford, Oxford, ,(2) Duke University Medical Center, Durham, NC, (3) Varian Medical Systems, Palo Alto, CA, (4) Elekta Ltd, Crawley, WSX, (5) University of Oxford, Oxford, United Kingdom |
